Childhood Hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2023-05-31
  Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma [Phase 3]

  Phase 3 trial evaluating brentuximab vedotin in combination chemotherapy for pediatric and young adult Hodgkin lymphoma across advanced-stag…

• CLINICAL_TRIALS trial_result · 2020-10-29
  Clinical Trial Update: Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer [Phase 3]

  Phase 3 trial comparing fixed versus flexible dosing of filgrastim to speed bone marrow recovery after chemotherapy in children; the study i…

• CLINICAL_TRIALS trial_result · 2019-05-29
  Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]

  Phase 2 clinical trial evaluating autologous peripheral blood stem cell transplant followed by donor bone marrow transplant in high-risk B- …

• CLINICAL_TRIALS trial_result · 2017-02-09
  Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma [Phase 3]

  Phase 3 trial of combination chemotherapy followed by radiation therapy in children with newly diagnosed Hodgkin lymphoma; results posted af…

• CLINICAL_TRIALS trial_result · 2014-02-24
  Clinical Trial Update: Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]

  Phase 1 study of oxaliplatin, ifosfamide, and etoposide in young patients with recurrent or refractory solid tumors or lymphomas; the trial …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2013-07-02
  Clinical Trial Update: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma [Phase 1]

  This phase 1 trial assessed safety and preliminary activity of the HDAC inhibitor vorinostat combined with bortezomib in pediatric patients …